Done sou Salè H1B

Akèy › Anplwayè › Merck Sharp & Dohme LLC › Associate Principal Scientist, Preclinical Development

Associate Principal Scientist, Preclinical Development nan Merck Sharp & Dohme LLC: Salè H-1B

6 aplikasyon kondisyon travay pou tit travay Associate Principal Scientist, Preclinical Development nan Merck Sharp & Dohme LLC. Salè baz medyàn ofri $140,354; mwatye mitan $136,525–$142,077.

Demann (LCA)6
Salè medyan ofri$140,354
Mwatye salè yo$136,525–$142,077
10yèm–90yèm pousantaj$135,250–$142,565

Pa ane fiskal

Ane fiskalLCASalè medyan
FY20242$135,250
FY20252$140,354
FY20262$142,565

Aplikasyon

Salè bazKoteSoumètDat kòmansmanEstati
$142,730–$224,100
Nivo IV
Rahway, NJJun 11, 2026Sep 30, 2026Certifye
$142,400–$224,100
Nivo III
Rahway, NJMay 27, 2026Jun 8, 2026Certifye
$139,600–$219,700
Nivo III
Rahway, NJAug 7, 2025Aug 18, 2025Certifye
$141,107–$213,000
Nivo IV
Rahway, NJJan 22, 2025Feb 24, 2025Certifye
$135,500–$213,400
Nivo III
Rahway, NJJul 1, 2024Jul 29, 2024Certifye
$135,000–$213,400
Nivo III
Rahway, NJJun 17, 2024Jul 1, 2024Certifye

Lòt travay nan Merck Sharp & Dohme LLC

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).